# EDGAR Filing Document

**Accession Number:** 0002035992
**File Stem:** 0001213900-25-115773
**Filing Date:** 2025-11
**Character Count:** 3639
**Document Hash:** 12864b86d4ee4d6aa1d30d6b95fbc3ec
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-115773.hdr.sgml**: 20251128

**ACCESSION NUMBER**: 0001213900-25-115773

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251128

**FILED AS OF DATE**: 20251128

**DATE AS OF CHANGE**: 20251128

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Charming Medical Ltd
- **CENTRAL INDEX KEY:** 0002035992
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42907
- **FILM NUMBER:** 251532386

**BUSINESS ADDRESS:**
- **STREET 1:** UNITS 1803-1U806, 18/F, HANG LUNG CENTRE
- **STREET 2:** 2-20 PATERSON STREET, CAUSEWAY BAY
- **CITY:** HONG KONG
- **STATE:** K3
- **ZIP:** 00000
- **BUSINESS PHONE:** 852 2116 1492

**MAIL ADDRESS:**
- **STREET 1:** UNITS 1803-1U806, 18/F, HANG LUNG CENTRE
- **STREET 2:** 2-20 PATERSON STREET, CAUSEWAY BAY
- **CITY:** HONG KONG
- **STATE:** K3
- **ZIP:** 00000

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of November 2025**

**Commission File Number: 001-42907**

**Charming Medical Limited**

**Units 1803-1806, 18/F, Hang Lung Centre<br> 2-20 Paterson Street, Causeway Bay, Hong Kong**

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

**Trading Halt Imposed by Nasdaq**

On November 26, 2025, the Nasdaq Stock Market LLC ("Nasdaq") announced that trading in the securities of Charming Medical Limited (the "Company") has been halted pending the Company's provision of certain additional information requested by Nasdaq. According to Nasdaq's public announcement, trading will remain halted until the Company has fully satisfied Nasdaq's request for such information.

As previously disclosed, on November 11, 2025, the U.S. Securities and Exchange Commission (the "SEC") issued an order suspending trading in the Company's securities for the period from 4:00 a.m. ET on November 12, 2025 through 11:59 p.m. ET on November 25, 2025. The SEC's order is available at: https://www.sec.gov/files/litigation/suspensions/2025/34-104176.pdf.

On November 12, 2025, the Company received an initial information request from Nasdaq in connection with the SEC suspension. Following the Company's prior Form 6-K filing on November 13, 2025, the Company promptly provided Nasdaq with the requested information. Should the Company receive any additional requests, it will address them in due course.<br>The Company is fully committed to cooperating fully with the SEC, Nasdaq, and other regulatory authorities as necessary. The Company's ongoing business operations remain normal, and there has been no material change to the Company's business operations or financial position as of the date of this report.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Charming Medical Limited** | **Charming Medical Limited** |
| Date: November 28, 2025 | By: | */s/ Kit Wong* |
|  | Name: | Kit Wong |
|  | Title: | Chief Executive Officer and |
|  |  | Chairman of the Board |

---